I rate Hinge Health a buy due to its patented technology, scalable model, and significant untapped market opportunity. TrueMotion's patented, AI-powered platform and FDA-cleared devices create high barriers to entry and enable rapid, cost-effective growth. HNGE's strong partnerships, high client retention, and integration with major health plans drive predictable revenue and market expansion.

J&J, Novartis and Allogene Therapeutics are making bold oncology moves as demand surges for next-generation cancer therapies.

For years, Tesla TSLA has been the undisputed face of the electric vehicle (EV) revolution. From sleek car designs to bold bets on self-driving tech and artificial intelligence, Tesla transformed the auto industry.

Shares in Rentokil Initial PLC (LSE:RTO) were given a short-lived boost by analysts at Deutsche Bank on Monday, who wondered if there might be improving organic trends in Rentokil's North America pest control business. The analysts, which nudged up their target price to 435p from 425p and reiterated their 'buy' rating, said this was based on analysis of several market indicators, including weather, employment and Google Trends in the US.

HLT's Q2 results are likely to reflect strength in fees and global growth, offset by leisure softness and cost headwinds.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Founder/CEO Ken Moelis is stepping down. But the fundamental case to own Moelis & Co remains as strong as ever. Moelis remains primed for an M&A-led rebound.

Recent ASCO data and UK MHRA approval for ANKTIVA reinforce my bullish thesis, despite the FDA's Refusal to File setback. ANKTIVA's potential to reverse lymphopenia in late-stage cancer patients could open significant new markets beyond bladder cancer. Major risks remain: FDA's RTF for sBLA and ImmunityBio's concerning cash position increase the likelihood of dilution.

COLUMBUS, Ohio , July 21, 2025 /PRNewswire/ -- Vertiv (NYSE: VRT), a global leader in critical digital infrastructure, today announced the appointment of Wei Shen as president of Greater China, effective July 22, 2025. Shen joins Vertiv from Gates Corporation, where he served as vice president, general manager – Greater China for nine years.

New pricing reflects added value, with more dining choices and shore excursion credits FT. LAUDERDALE, Fla.

JNJ jumps over 6% on Q2 earnings beat and full-year guidance increase, driven by strong pharma sales and improved MedTech sales.

With no revenue expected, VKTX's Q2 report is likely to have the spotlight on pipeline moves across its obesity drugs.

Here is how DexCom (DXCM) and Amarin (AMRN) have performed compared to their sector so far this year.